| 2026-08-11 | Press release | NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance |
| 2026-07-28 | Press release | NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy |
| 2026-05-29 | Press release | NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Fu |
| 2026-05-12 | Press release | NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance |
| 2026-05-12 | Presentation | Download PDF file, (opens in new window) |
| 2026-05-12 | Press release | NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026 |
| 2026-04-27 | Press release | NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in N |
| 2026-03-05 | Press release | NeuroPace to Present at the Leerink Global Healthcare Conference |
| 2026-03-03 | Press release | NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook |
| 2026-03-03 | Press release | NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026 |
| 2026-01-13 | Press release | NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook |
| 2026-01-12 | Presentation | 44th Annual J.P. Morgan Healthcare Conference Presentation Open Event Link, PDF file, January 14, 2026, (opens in new wi |
| 2025-12-31 | Press release | NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference |
| 2025-12-17 | Press release | NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy |
| 2025-12-08 | Press release | NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy |
| 2025-12-02 | Press release | NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) |
| 2025-11-24 | Press release | NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services |
| 2025-10-22 | Press release | NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025 |
| 2025-08-12 | Press release | NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance |
| 2025-08-01 | Press release | NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases |
| 2025-07-29 | Press release | NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025 |
| 2025-06-24 | Press release | NeuroPace Announces Strategic CFO Transition |
| 2025-06-04 | Press release | NeuroPace Secures Up to $75 Million in Debt Financing |
| 2025-05-27 | Press release | NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study |
| 2025-05-13 | Press release | NeuroPace Reports First Quarter 2025 Financial Results |
| 2025-04-18 | Annual report | Annual Report of 2024 Annual Report, PDF file, (opens in new window) |
| 2025-04-14 | Press release | NeuroPace Provides Update on Tariff Status |
| 2025-04-08 | Press release | NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual |
| 2025-04-03 | Press release | NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2 |
| 2025-04-02 | Press release | NeuroPace Announces Refocusing of Product Portfolio |
| 2025-03-26 | Press release | NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference |
| 2025-03-04 | Press release | NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results |
| 2025-03-04 | Press release | Q4 |
| 2025-02-20 | Press release | NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd. |
| 2025-01-28 | Presentation | NeuroPace In-Person Investor Day Presentation Open Event Link, PDF file, January 28, 2025, (opens in new window) |
| 2025-01-01 | Presentation | 43rd Annual JP Morgan Healthcare Conference |
| 2024-11-12 | Press release | Q3 |
| 2024-08-13 | Press release | Q2 |
| 2024-05-08 | Press release | Q1 |